Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.
| Calcium D-Glucarate | NMN (Nicotinamide Mononucleotide) | |
|---|---|---|
| Category | Supplements | Supplements |
| Standard Dose | 500-1500mg daily | 500-1000mg daily |
| Timing | With meals, split 2-3x/day for sustained beta-glucuronidase inhibition. | Morning on empty stomach. Sublingual absorption bypasses first-pass metabolism. |
| Cycle Duration | ongoing or cycle with DIM protocol | ongoing |
| Evidence Level | moderate_human | moderate_human |
Calcium D-glucarate is the calcium salt of D-glucaric acid, which is metabolized to D-glucaro-1,4-lactone (the active metabolite). This lactone inhibits beta-glucuronidase, the bacterial enzyme in the gut that deconjugates (cleaves) glucuronide conjugates from Phase II detoxification. By inhibiting beta-glucuronidase, calcium D-glucarate prevents the reabsorption (enterohepatic recirculation) of estrogen, environmental toxins, and carcinogens that were already conjugated for excretion. This effectively enhances the elimination of glucuronidated compounds, including estrogen metabolites, bilirubin, and xenobiotics.
500-1500mg daily
With meals, split 2-3x/day for sustained beta-glucuronidase inhibition.
ongoing or cycle with DIM protocol
NMN is a direct biosynthetic precursor to NAD+ via the salvage pathway enzyme nicotinamide phosphoribosyltransferase (NAMPT). Elevated NAD+ activates sirtuins (SIRT1-7), PARP DNA repair enzymes, and CD38/CD157 signaling. SIRT1 activation deacetylates PGC-1alpha (mitochondrial biogenesis), FOXO transcription factors (stress resistance), and NF-kB (anti-inflammatory). NMN also enters cells via the Slc12a8 transporter, recently identified in the gut.
500-1000mg daily
Morning on empty stomach. Sublingual absorption bypasses first-pass metabolism.
ongoing
Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.
Get Your Free Protocol →or take the assessment →